Does chemotherapy improve survival outcomes in breast cancer survivors with secondary primary stage I non-small cell lung cancer? A real-world analysis using machine learning models.

Regarding the staging of breast cancer, patients with non-metastatic breast cancer may still derive benefits from lung cancer-related adjuvant chemotherapy; however, the statistical difference in chemotherapy benefits for stage III breast cancer patients is not yet significant, potentially due to a smaller sample size.

also in 316 other papers